Background: Autologous hematopoietic stem cell transplantation (AHSCT) is a standard treatment for lymphoma, yet it is associated with psychological distress. Omaha System-based care offers a structured approach to address the unique needs of patients undergoing AHSCT.
Objective: This study aims to evaluate the efficacy and utility of Omaha System-based care in patients undergoing autologous hematopoietic stem cell transplantation (AHSCT) for lymphoma (LY), focusing particularly on its impact on psychological well-being.
Methods: The study adopted an observational design and included 80 LY patients undergoing AHSCT at our hospital between January 2022 and December 2022. Of these, 46 patients received Omaha System-based care (observation group), while 34 patients received conventional care (control group). Pre- and post-intervention assessments comprised the Self-rating Anxiety/Depression Scale (SAS/SDS), Pittsburgh Sleep Quality Index (PSQI), and Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT). Additionally, the duration of stay in the laminar airflow bio-clean room (LAFR), total hospital stays, hospitalization expenses, and incidence of adverse reactions were recorded. Nursing satisfaction was also evaluated.
Results: Post-intervention, the observation group exhibited significantly lower SAS, SDS, and PSQI scores compared to the control group (P < .05), indicating improved psychological well-being. Moreover, the observation group demonstrated a shorter hospital stay (P < .05), reduced healthcare expenditures, lower incidence of adverse reactions, and higher nursing satisfaction (P < .05).
Conclusions: Omaha System-based care demonstrates promising outcomes in enhancing the safety and psychological well-being of LY patients undergoing AHSCT. The findings underscore its potential as an effective intervention to optimize patient care in this population. Further research is warranted to validate these results and facilitate their broader adoption in clinical practice.